This map shows the geographic impact of H Schicha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Schicha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Schicha more than expected).
This network shows the impact of papers produced by H Schicha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Schicha. The network helps show where H Schicha may publish in the future.
Co-authorship network of co-authors of H Schicha
This figure shows the co-authorship network connecting the top 25 collaborators of H Schicha.
A scholar is included among the top collaborators of H Schicha based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H Schicha. H Schicha is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Hellmich, Martin, et al.. (2013). Krankheitsfreies Überleben bei papillärem und follikulärem Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 52(3). 71–80.4 indexed citations
2.
Kobe, Carsten, Mathias Schmidt, Deniz Kahraman, et al.. (2012). Calcitonin-Screening bei Patienten mit Schilddrüsenknoten – Diagnostische Bedeutung. Nuklearmedizin - NuclearMedicine. 51(6). 228–233.4 indexed citations
3.
Dietlein, Markus, et al.. (2010). Rekombinantes humanes TSH im Vergleich zur Hypothyreose. Nuklearmedizin - NuclearMedicine. 49(6). 216–224.12 indexed citations
4.
Riemann, B., K. W. Schmid, Henning Dralle, et al.. (2010). Risikostratifizierung von Patienten mit lokal aggressiven differenzierten Schilddrüsenkrebs – Ergebnisse der MSDS-Studie. Nuklearmedizin - NuclearMedicine. 49(3). 79–84.21 indexed citations
5.
Dietlein, Markus, Thomas Fischer, Hinrich P. Hansen, et al.. (2010). Entwicklung von Anti-CD30-Radioimmunkonstrukten zur Behandlung des Hodgkin-Lymphoms – Studien an Zellkulturen und Tieren. Nuklearmedizin - NuclearMedicine. 49(3). 97–105.6 indexed citations
6.
Dietlein, Markus, et al.. (2008). Adipositas, Stoffwechsel und Schilddrüse Ist der grenzwertig hohe TSH-Spiegel Ursache oder Sekundärphänomen der Adipositas?. Nuklearmedizin - NuclearMedicine. 47(5). 181–187.9 indexed citations
7.
Kobe, Carsten, W. Eschner, F. Sudbrock, et al.. (2008). Morbus Basedow - Hängt der Erfolg der Radioiodablation von der thyreostatischen Medikation ab?. Nuklearmedizin - NuclearMedicine. 47(4). 153–166.9 indexed citations
Dietlein, Markus, et al.. (2003). [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].. PubMed. 42(4). 135–44.14 indexed citations
11.
Dietlein, Markus, Wolfgang Weber, Markus Schwaiger, & H Schicha. (2003). [18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer].. PubMed. 42(4). 145–56.4 indexed citations
12.
Dietlein, Markus, et al.. (2001). [Cost-effectiveness of PET in the management algorithms of lung tumors: comparison of health economic data].. PubMed. 40(4). 122–8.4 indexed citations
13.
Voth, E., et al.. (2000). [Sonographic determination of thyroid volume--comparison with surgical data].. PubMed. 39(4). 102–7.9 indexed citations
14.
Dietlein, Markus, et al.. (1999). [Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization].. PubMed. 93(1). 49–55.
15.
Dietlein, Markus, et al.. (1999). Cost-effectiveness-analysis: Radioiodine or Antithyroid Drugs as First-line Therapy of Hyperthyroidism due to Graves' Disease. 38(1). 7–14.3 indexed citations
16.
Smolarz, Katarzyna, W. Eschner, & H Schicha. (1998). [Influence of disease prognosis and age on the radiation risk from diagnostic nuclear medicine (bone scintigraphy as an example)].. PubMed. 37(8). 286–91.2 indexed citations
17.
Schicha, H, et al.. (1996). [Influence of physiological and pharmacological amounts of iodine on the 131I uptake of the thyroid gland--a model calculation].. PubMed. 35(6). 251–63.2 indexed citations
18.
Schicha, H, et al.. (1980). [Qualitative and semi-quantitative analysis of local wall motion abnormalities by gated-blood-pool in comparison to biplane cineventriculography (author's transl)].. PubMed. 69(5). 334–8.1 indexed citations
19.
Luig, H., R Reuter, D. Emrich, et al.. (1979). [The determination of the left ventrical volume curve without background correction and its validation by direct intercomparison with the ejection fractions as determined by biplane laevocardiography (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(3). 120–4.3 indexed citations
20.
Schicha, H, et al.. (1978). [Studies on the lymph drainage of the eye 5. Quantitative registration of the lymph drainage from the subconjunctival space with a radioactive tracer (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 172(6). 872–6.6 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.